Browsing by Author Swarbrick, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2013Annexin A6 is a scaffold for PKC(alpha) to promote EGFR inactivationCairns, Rose; Grewal, (Ranjit) Thomas; Hoque, Monira; Koese, Meryem; Kota, Bhavani; Wood, Peta; Alvarez-Guaita, Anna; Daly, Roger; Enrich, Carlos; Hughes, William E; Monastyrskaya, Katia; Rentero, Carles; Reverter, M; Swarbrick, A.; Tebar, Francesc; Vila de Muga, Sandra; Pharmacy; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyAnnexin A6 is a scaffold for PKC(alpha) to promote EGFR inactivation, Oncogene, vol.32, 23, 2013,pp 2858-2872
2014c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancerArmstrong, Nicola Joy; Naylor, Matthew; O'Toole, Sandra; Baker, Laura; Cowley, Mark; Herschkowitz, Jason I; Hui, Mun; Junankar, Simon; Kaplan, Warren; Lakhani, Sunil R.; McFarland, Andrea; Morey, Adrienne; Nair, Radhika; Nguyen, Akira; Nicolic, I; Ormandy, Christopher J.; Perou, Charles M; Pfefferle, Adam; Roden, Daniel; Selinger, Christina; Shah, Jaynish; Swarbrick, A.; Teo, W S; Usary, Jerry E; Yang, J; Ye, S; Mathematics & Statistics; School of Medical Sciences: Physiology; Central Clinical School: Pathologyc-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer, Oncogene, vol.33, 30, 2014,pp 3992-4002
2014Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Castillo, Lesley; Chiam, K; Clark, Susan J.; Daly, R; Lee, B Y; Lin, H-M; Mallesara, G; Nguyen, Q; Swarbrick, A.; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreCirculating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer, British Journal of Cancer, vol.110, 10, 2014,pp 2462-2471
2011Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast CancerCooper, Caroline; O'Toole, Sandra; Christ, Daniel; Hannigan, Gregory E.; Machalek, Dorothy A.; Martelotto, Luciano G.; McFarland, Andrea; McLeod, Duncan; McNeil, Catriona M.; Millar, Ewan; Musgrove, Elizabeth A.; Nair, Radhika; Nguyen, Akira; Ormandy, Christopher J.; Qiu, Min Ru; Rabinovich, Brian; Schofield, Peter R.; Shearer, Robert F.; Sutherland, Robert L.; Swarbrick, A.; Vu, Duc; Watkins, D. Neil; Central Clinical School: Pathology; Central Clinical School: PathologyHedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer, Cancer Research, vol.71, 11, 2011,pp 4002-4014
2009The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.O'Toole, Sandra; Sutherland, Robert L.; Swarbrick, A.; Central Clinical School: PathologyThe Hedgehog signalling pathway as a therapeutic target in early breast cancer development., Expert Opinion on Therapeutic Targets, vol.13, 9,pp 1095-1103
2013The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapyO'Toole, Sandra; Cazet, Aurelie; Hui, Mun; Nair, Radhika; Swarbrick, A.; Watkins, D. Neil; Central Clinical School: PathologyThe Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy, Breast Cancer Research, vol.15, 2, 2013,pp 1-14
2014Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathwaysArmstrong, Nicola Joy; Ali, Naveid; Chan, Howard; Clark, S; Daly, Roger; Hochgrafe, Falko; Lee, Hongching; Lyons, Ruth J.; Nair, Radhika; Ormandy, Christopher J.; Pinese, Mark; Swarbrick, A.; Wu, Jianmin; Ye, S; Zhang, Luxi; Mathematics & StatisticsProfiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways, Breast Cancer Research, vol.16, 5, 2014,pp 1-19
2016Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcomeBeith, Jane; Carmalt, Hugh; Chan, Charles; Cooper, Caroline; Gee, Harriet; Gillett, David; Gluch, Laurence; Kennedy, Catherine; McLean, Anna; McNeil, Catriona; O'Toole, Sandra; Scolyer, Richard; Vilain, Ricardo; Walker, Emily; Warrier, Sanjay; Wilmott, James; Beckers, Rhiannon; Harvey, Kate; Holliday, Anne; Madore, Jason; Mak, Cindy; Robbins, Elizabeth; Selinger, Christina; Swarbrick, A.; Central Clinical School: Medicine; Concord Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Medicine; Concord Clinical School: Surgery; Central Clinical School: Medicine; Central Clinical School: Surgery; Northern Clinical School: Rehabilitations Studies Unit; Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; Central Clinical School: Pathology; Central Clinical School: Pathology; Medicine; Central Clinical School: Surgery; Central Clinical School: SurgeryProgrammed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome, Histopathology, vol.69, 1, 2016,pp 25-34
2010Redefining the expression and function of the inhibitor of differentiation 1 in mammary gland developmentO'Toole, Sandra; Bishop, J; Borowsky, Alexander; Junankar, Simon; Nair, Radhika; Shah, Jaynish; Swarbrick, A.; Central Clinical School: PathologyRedefining the expression and function of the inhibitor of differentiation 1 in mammary gland development, PLoS One, vol.5, 8,pp 1-7
2013Therapeutic targets in triple negative breast cancerBeith, Jane; McLean, Anna; O'Toole, Sandra; West, Richard; Cazet, Aurelie; Millar, Ewan; Oakes, Samantha; Swarbrick, A.; Central Clinical School: Medicine; Northern Clinical School: Rehabilitations Studies Unit; Central Clinical School: Pathology; Central Clinical School: SurgeryTherapeutic targets in triple negative breast cancer, Journal of Clinical Pathology, vol.66, 6, 2013,pp 530-542